Home » Stocks » CONMED Corporation

CONMED Corporation (CNMD)

Stock Price: $85.15 USD -1.31 (-1.52%)
Updated Aug 14, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 2.43B
Revenue (ttm) 870.25M
Net Income (ttm) 431,000
Shares Out 28.57M
EPS (ttm) 0.02
PE Ratio 4,257.50
Forward PE n/a
Dividend $0.80
Dividend Yield 0.94%

Stock Quote

Trading Day Aug 14, 2020
Last Price $85.15
Previous Close $86.46
Change ($) -1.31
Change (%) -1.52%
Day's Open 85.23
Day's Range 84.61 - 85.67
Day's Volume 114,030
52-Week Range 37.66 - 116.81

More Stats

Market Cap 2.43B
Enterprise Value 3.20B
Earnings Date (est) Oct 29, 2020
Ex-Dividend Date Jun 12, 2020
Shares Outstanding 28.57M
Float 28.25M
EPS (basic) 0.03
EPS (diluted) 0.02
FCF / Share 2.42
Dividend $0.80
Dividend Yield 0.94%
Earnings Yield 0.02%
FCF Yield 2.84%
Payout Ratio n/a
Shares Short 846,967
Short Ratio 5.93
Short % of Float 8.87%
Beta 1.25
PE Ratio 4,257.50
Forward PE n/a
P/FCF Ratio 35.21
PS Ratio 2.80
PB Ratio 3.64
Revenue 870.25M
Operating Income 39.93M
Net Income 431,000
Free Cash Flow 69.10M
Net Cash -770.64M
Net Cash / Share -26.97
Gross Margin 60.78%
Operating Margin 4.59%
Profit Margin n/a
FCF Margin 7.94%
ROA 2.38%
ROE 0.06%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$98.40*
(15.56% upside)
Low
92.0
Current: $85.15
High
110.0
Target: 98.40
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue955860796764719740763767725714
Revenue Growth11.11%7.94%4.31%6.17%-2.82%-2.97%-0.58%5.8%1.59%-
Gross Profit525469431408382404412406375365
Operating Income73.9371.3146.9434.7351.1852.7956.5165.218.2757.09
Net Income28.6240.8555.4914.6630.5032.1935.9440.480.7530.35
Shares Outstanding28.3828.1327.9327.8227.7027.5327.6128.4927.9228.12
Earnings Per Share0.971.411.970.521.091.161.281.410.031.05
EPS Growth-31.21%-28.43%278.85%-52.29%-6.03%-9.38%-9.22%4600%-97.14%-
Dividend Per Share0.800.800.800.800.800.800.650.60--
Dividend Growth0%0%0%0%0%23.08%8.33%---
Operating Cash Flow95.1374.7065.5739.8850.9265.1880.9595.2010338.24
Capital Expenditures-20.07-16.51-12.84-9.58-15.01-15.41-18.45-19.70-17.55-14.73
Free Cash Flow75.0758.1952.7230.3135.9149.7762.5075.5085.4423.51
Cash & Equivalents25.8617.5132.6227.4372.5066.3354.4423.7226.0512.42
Total Debt769457486498271241216162144196
Net Cash / Debt-743-439-454-471-198-175-161-138-117-183
Assets1,7751,3691,3581,3291,1021,0981,0911,079936986
Liabilities1,065707727748517517484472363399
Book Value710662631581585581606607573587
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name CONMED Corporation
Country United States
Employees 3,300
CEO Curt R. Hartman

Stock Information

Ticker Symbol CNMD
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: CNMD
IPO Date July 23, 1987

Description

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; and endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.